🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and immune response to two experimental vaccines when ...
Status
Completed
Location
JHU AVEG
Start Date
TBD
Trial ID
NCT00001096
Treatments Being Tested
Malaria is a disease that affects many people in Africa. Malaria is caused ...
Status
Completed
Location
University of Bamako, Malaria Research and Training Center
Start Date
2007-05
Trial ID
NCT00460525
Treatments Being Tested
The purpose of this study is to see if two new malaria vaccines called FMP1...
Status
Completed
Location
WRAIR Clinical Trials Center
Start Date
2001-04
Trial ID
NCT01556945
Treatments Being Tested
This is a Phase I, randomized, double-blind, placebo-controlled clinical st...
Status
Recruiting
Location
Makerere University Walter Reed Project (MUWRP)
Start Date
2024-01-30
Trial ID
NCT06205056
Treatments Being Tested
The purpose of this long term extension study is to assess safety, tolerabi...
Status
Terminated
Location
Meitetsu Hospital
Start Date
2010-12
Trial ID
NCT01238991
The purpose of this study is to assess the safety and tolerability of VBI-1...
Status
Terminated
Location
University of California, Irvine
Start Date
2017-12-06
Trial ID
NCT03382977
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and immuno...
Status
Completed
Location
Tazuke Kofukai Medical Research Institute Kitano Hospital
Start Date
2009-08
Trial ID
NCT00959192
The study is to evaluate the safety, tolerability and whether there is an i...
Status
Completed
Location
Suwa Red Cross Hospital
Start Date
2008-12
Trial ID
NCT00752232
The purpose of this study is to evaluate the safety and immunogenicity of H...
Status
Completed
Location
Alabama CRS
Start Date
2020-01-13
Trial ID
NCT04177355
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-06
Trial ID
NCT00003819
Treatments Being Tested